The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-Benzyl-3-(((4-phenyl-3-(pyridin-4-yl)-1H-pyrazol-5-yl)methyl)-amino)benzamide ID: ALA4099309
PubChem CID: 137660696
Max Phase: Preclinical
Molecular Formula: C29H25N5O
Molecular Weight: 459.55
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(NCc1ccccc1)c1cccc(NCc2[nH]nc(-c3ccncc3)c2-c2ccccc2)c1
Standard InChI: InChI=1S/C29H25N5O/c35-29(32-19-21-8-3-1-4-9-21)24-12-7-13-25(18-24)31-20-26-27(22-10-5-2-6-11-22)28(34-33-26)23-14-16-30-17-15-23/h1-18,31H,19-20H2,(H,32,35)(H,33,34)
Standard InChI Key: WRBFHBIIEVVYIJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
35 39 0 0 0 0 0 0 0 0999 V2000
14.7891 -17.6344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1471 -18.1408 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.2633 -18.9545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0250 -19.2588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6751 -18.7472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5514 -17.9314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4319 -19.0559 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6737 -19.8425 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.4918 -19.8604 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.7630 -19.0883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1091 -18.5842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5597 -18.8532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1481 -19.4289 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.5100 -19.7884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2945 -19.5749 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5122 -18.7797 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9311 -18.2027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1367 -18.4195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9272 -19.2115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1403 -17.4086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9331 -17.1906 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.5607 -16.8283 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.1423 -16.3965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9352 -16.1827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5152 -16.7648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3074 -16.5473 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5172 -15.7566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9328 -15.1753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1428 -15.3916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1290 -17.7631 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8501 -17.3764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8703 -16.5520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1681 -16.1255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4441 -16.5210 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4274 -17.3401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 2 0
8 9 1 0
9 10 1 0
10 11 2 0
11 7 1 0
10 12 1 0
12 13 1 0
19 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
13 19 1 0
17 20 1 0
20 21 1 0
20 22 2 0
21 23 1 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 24 1 0
11 30 1 0
30 31 2 0
31 32 1 0
32 33 2 0
33 34 1 0
34 35 2 0
35 30 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 459.55Molecular Weight (Monoisotopic): 459.2059AlogP: 5.68#Rotatable Bonds: 8Polar Surface Area: 82.70Molecular Species: NEUTRALHBA: 4HBD: 3#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 3.79CX LogP: 4.66CX LogD: 4.66Aromatic Rings: 5Heavy Atoms: 35QED Weighted: 0.28Np Likeness Score: -1.23
References 1. Okawa T, Aramaki Y, Yamamoto M, Kobayashi T, Fukumoto S, Toyoda Y, Henta T, Hata A, Ikeda S, Kaneko M, Hoffman ID, Sang BC, Zou H, Kawamoto T.. (2017) Design, Synthesis, and Evaluation of the Highly Selective and Potent G-Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor for the Potential Treatment of Heart Failure., 60 (16): [PMID:28699740 ] [10.1021/acs.jmedchem.7b00443 ]